The Jackson Laboratory collaborates to help the NIH fight rare diseases

Independent nonprofit biomedical research institute The Jackson Laboratory (JAX) has teamed with Lovelace Biomedical, Exemplar Genetics, Iontox and the University of Pennsylvania to win a new $17M contract with the National Institute of Health’s National Center for the Advancement of Translational Sciences, for the purposes of creating new animal models and performing pharmacology studies to better understand and study diseases or treatments, especially for rare and neglected diseases.  The combined capabilities of the team members represent some of the best talents in the world to help the NIH in creating or characterizing novel disease models to address unmet needs.  Diseases such as sickle cell disease or other ailments have been difficult to fight without proper animal model resources, indicates Dr. Jake McDonald, Principal Investigator of the overall contract. Read more

Related Posts

On the Record: Roux Institute’s Lars Perkins helps startups take off

Lars Perkins, a former software entrepreneur, Google executive and certified flight instructor who once flew planes for lifesaving “adventure philanthropy,” is managing...

28 November 2022

UNE to begin building new medical school at Portland campus

The University of New England is about to start a $93 million project to move the state’s only medical school from...

28 November 2022

Portland Planning Board recommends zoning changes for Roux Institute redevelopment

The Portland Planning Board is recommending that the city adopt zoning changes requested by the developers of a new graduate school...

22 November 2022